
Browsing restrictions can be lifted for a fee.
Spirox Corporation provides integrated solutions to the semiconductor, electronics manufacturing, telecom, and automobile markets worldwide. The company offers wafer level test handlers, tri-temp strip level test systems, motion simulators, thermal chuck systems, warpage adjustment systems, high-resolution emission microscopes, thermal and inverted emission microscopes, electrostatic discharge (ESD) test-wafer, ESD/latch-up test-package level, TLP tester, semiconductor test systems, CDMs, semiconductor packages and PCB inspection equipment, mass production test handlers, power module handlers, semiconductor probe equipment, AC and DC test systems, fluxless reflow and wet blaster systems, wafer inspection systems, FE/BE dockings, direct dock systems, hander interface board locks, stiffeners, and LCD driver IC test systems. It also provides reliability testing, ESD testing, failure analysis, circuit edit, and functional safety certification consulting services. The company was founded in 1987 and is headquartered in Hsinchu City, Taiwan.
3055
蔚華科
-5.11%
(-0.05)
The most recent financial report for 蔚華科 (3055) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3055's short-term business performance and financial health. For the latest updates on 3055's earnings releases, visit this page regularly.
According to the latest financial report, 蔚華科 (3055) reported an Operating Profit of -56.62M with an Operating Margin of -59.55% this period, representing a growth of 8.22% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 蔚華科 (3055) announced revenue of 95.09M, with a Year-Over-Year growth rate of -56.91%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 蔚華科 (3055) held Total Cash and Cash Equivalents of 889.73M, accounting for 0.43 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 蔚華科 (3055) did not achieve the “three margins increasing” benchmark, with a gross margin of 1.88%%, operating margin of -59.55%%, and net margin of -25.07%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3055's profit trajectory and future growth potential.
According to the past four quarterly reports, 蔚華科 (3055)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.15. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
蔚華科 (3055)'s Free Cash Flow (FCF) for the period is -53.79M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 202.95% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.